Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib and Etanercept in Painful Temporomandibular Joints
NCT00001955Phase 2Completed
- Sponsor
- National Institute of Dental and Craniofacial Research
- Start
- Dec 1999
- Modality
- Orthosteric Ligands, Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of celecoxib and etanercept in temporomandibular joint disorder (TMJ) (5 arms), sponsored by National Institute of Dental and Craniofacial Research. Primary endpoint: Pain Intensity and Magnitude at 6 weeks. Started Dec 1999; status: completed.
02
Drugs
celecoxibetanercept
03
Conditions
temporomandibular joint disorder (TMJ)
Beyond the preview
Go deeper on NCT00001955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001955.